Menu Back toCMC Considerations for Accelerated Development of Advanced Therapy Products

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone


CMC Considerations for Accelerated Development of Advanced Therapy Products

Speaker(s)

Jun  Park, PhD

Jun Park, PhD

  • EVP/Chief Technology Officer
  • ILIAS Biologics, Inc., Korea, Republic of

Contact us

Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574